Salivary Metabolomics Discloses Metabolite Signatures of Oral Leukoplakia with and Without Dysplasia
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136519 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Elena Ferrari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Metabolomics, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy. Hauptthemen laut MEDLINE: Leukoplakia, Oral, Metabolomics, Saliva, Metabolome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Leukoplakia is a condition marked by white patches on the inner surfaces of the oral cavity. Its potential to progress to oral squamous cell carcinoma underscores the need for effective screening and early diagnosis procedures. We employed NMR-based salivary and tissue metabolomics to identify potential biomarkers for leukoplakia and dysplastic leukoplakia. Univariate and multivariate methods were used to evaluate the NMR-derived metabolite concentrations. The salivary metabolite profile of leukoplakia exhibited specific alterations compared to healthy controls. These metabolic changes were more pronounced in cases of dysplastic lesions. Multivariate ROC curve analysis, based on a selection of salivary metabolites, ascribed high diagnostic accuracy to the models that discriminate between dysplastic and healthy cases. However, NMR analysis of tissue biopsies was ineffective in extracting metabolic signatures to differentiate between lesional, peri-lesional, and healthy tissues. Our pilot study employing a metabolomics-based approach led to the development of salivary models that represent a complementary strategy for clinically detecting leukoplakia. However, larger-scale validation is required to fully evaluate their diagnostic potential and to effectively stratify leukoplakia patients according to dysplasia status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry and Metabolomics, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
- Centro Universitario Odontoiatria, University of Parma, Via Gramsci 14, 43126 Parma, Italy.
- Dentistry and Oral-Maxillofacial Surgery Unit, University of Modena and Reggio Emilia, 41125 Modena, Italy.
- Department of Chemical and Geological Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
- Department for Life Quality Studies, University of Bologna, 47921 Rimini, Italy.
- Dermatology Unit, Department of Surgical, Medical, Dental & Morphological Sciences with Interest Transplant, Oncological & Regenerative Medicine, University of Modena and Reggio Emilia, 41125 Modena, Italy.
ORCID-Profile: Rita Antonelli, Mariana Gallo, Giacomo Setti, Adele Mucci, Valeria Righi, Alberto Spisni, Thelma A Pertinhez
Zitieren
APA
Ferrari, E., Antonelli, R., Gallo, M., Meleti, M., Setti, G., Mucci, A., Righi, V., Gambini, A., Magnoni, C., Spisni, A., & Pertinhez, T. A. (2025). Salivary Metabolomics Discloses Metabolite Signatures of Oral Leukoplakia with and Without Dysplasia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136519
Vancouver
Ferrari E, Antonelli R, Gallo M, Meleti M, Setti G, Mucci A, et al. Salivary Metabolomics Discloses Metabolite Signatures of Oral Leukoplakia with and Without Dysplasia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136519
BibTeX
@article{Ferrari2025,
author = {Ferrari, Elena and Antonelli, Rita and Gallo, Mariana and Meleti, Marco and Setti, Giacomo and Mucci, Adele and Righi, Valeria and Gambini, Anna and Magnoni, Cristina and Spisni, Alberto and Pertinhez, Thelma A},
title = {Salivary Metabolomics Discloses Metabolite Signatures of Oral Leukoplakia with and Without Dysplasia},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136519}
}
EUVIMED